Clinical trial

Edwards Cardioband European Post-Market Study, MiBAND

NCT03600688 · Edwards Lifesciences, Industry · Unknown status

Key facts

NCT number NCT03600688
Title Edwards Cardioband European Post-Market Study, MiBAND
Official title Transcatheter Repair of Mitral Regurgitation With Cardioband System Post Market Study:A European Prospective, Multicenter Study to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System in Patients With Symptomatic MR
Acronym MiBAND
Lead sponsor Edwards Lifesciences, Industry
Status Unknown status
Study type Observational
Conditions Mitral Regurgitation, Mitral Insufficiency, Mitral Repair, Mitral Valve, Annuloplasty, Edwards Cardioband
Intervention type Device
Interventions Edwards Cardioband System
Enrollment 200
Start date Jun 6, 2018
Primary completion Dec 30, 2023
Completion Dec 31, 2023
First posted Jul 26, 2018
Last update posted Jan 26, 2023
Countries Germany, Italy, Switzerland

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies